Thought Leadership

Latest Report


Vantage Pharma, Biotech & Medtech 2019 in Review

2019 was a standout year for biopharma, anchored by strong fourth quarter markets and dealmaking. Following a difficult end to 2018, the biopharma industry recovered impressively to achieve an excellent 2019. A fourth-quarter surge on the stock markets meant that many companies ended the year on a high note, as investors flocked to drug developers…

Report library


Vantage 2019 Preview

2019 expected to be volatile year for pharma and biotech industries The Vantage 2019 Preview looks at the risks and opportunities for the year ahead. Report…